LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

Search

West Pharmaceutical Services Inc

Slēgts

SektorsVeselības aprūpe

335.99 2

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

325

Max

336.26

Galvenie mērījumi

By Trading Economics

Ienākumi

6.7M

139M

Pārdošana

40M

845M

P/E

Sektora vidējais

44.079

49.712

EPS

2.13

Dividenžu ienesīgums

0.26

Peļņas marža

16.428

Darbinieki

10,800

EBITDA

9M

219M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+13.13% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

0.26%

2.36%

Nākamie ieņēmumi

2026. g. 23. jūl.

Nākamais dividenžu datums

2026. g. 5. aug.

Nākamais Ex dividenžu datums

2026. g. 29. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

3.3B

23B

Iepriekšējā atvēršanas cena

333.99

Iepriekšējā slēgšanas cena

335.99

Ziņu noskaņojums

By Acuity

50%

50%

143 / 342 Rangs Healthcare

West Pharmaceutical Services Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Par West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat